"Tryptophan Oxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.
| Descriptor ID |
D014366
|
| MeSH Number(s) |
D08.811.682.690.416.722
|
| Concept/Terms |
Tryptophan Oxygenase- Tryptophan Oxygenase
- Oxygenase, Tryptophan
- Tryptophan 2,3-Dioxygenase
- 2,3-Dioxygenase, Tryptophan
- Tryptophan 2,3 Dioxygenase
- TDO Dioxygenase
- Dioxygenase, TDO
- Tryptophan Pyrrolase
- Pyrrolase, Tryptophan
|
Below are MeSH descriptors whose meaning is more general than "Tryptophan Oxygenase".
Below are MeSH descriptors whose meaning is more specific than "Tryptophan Oxygenase".
This graph shows the total number of publications written about "Tryptophan Oxygenase" by people in this website by year, and whether "Tryptophan Oxygenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tryptophan Oxygenase" by people in Profiles.
-
Quantification of IDO1 enzyme activity in normal and malignant tissues. Methods Enzymol. 2019; 629:235-256.
-
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy. Clin Cancer Res. 2015 Dec 15; 21(24):5427-33.
-
Overcoming immune resistance in the tumor microenvironment by blockade of indoleamine 2,3-dioxygenase and programmed death ligand 1. Curr Opin Investig Drugs. 2004 Dec; 5(12):1279-83.
-
Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003 Dec; 4(12):1206-12.
-
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.